fludarabine has been researched along with Polyneuropathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, M; Iwata, A; Koya, J; Kurokawa, M; Nagashima, Y; Nakamura, F; Tsuji, S | 1 |
| Brannagan, TH; Leitch, MM; Sherman, WH | 1 |
| Eurelings, M; Fijnheer, R; Franssen, H; Lokhorst, H; Niermeijer, JM; Notermans, NC; Wokke, JH | 1 |
1 trial(s) available for fludarabine and Polyneuropathies
| Article | Year |
|---|---|
Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy.
Topics: Aged; Aged, 80 and over; Female; Follow-Up Studies; Humans; Immunoglobulin M; Male; Middle Aged; Paraproteinemias; Polyneuropathies; Prospective Studies; Vidarabine | 2006 |
2 other study(ies) available for fludarabine and Polyneuropathies
| Article | Year |
|---|---|
Fludarabine may overcome resistance to rituximab in IgM-related neuropathy.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Drug Resistance; Female; Humans; Immunoglobulin M; Male; Middle Aged; Polyneuropathies; Rituximab; Vidarabine | 2012 |
Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide.
Topics: Cyclophosphamide; Disease Progression; Female; Humans; Immunosuppressive Agents; Middle Aged; Neural Conduction; Peripheral Nerves; Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Treatment Outcome; Vidarabine | 2013 |